AMA president Jack Resneck, Jr., MD, and dermatologist David M. Pariser, MD, FAAD, tell us their thoughts and experiences on the challenges patients face in accessing methotrexate for psoriasis and other autoimmune diseases.
A look into increased cardiovascular risk in patients who are transgender and suggestions for how to improve their health care.
Apps for detecting sleep apnea are increasingly popular, but are they effective — and is the data they generate relevant for clinicians?
Experts discuss the clinical features of, treatments for, and need for further research on the topic of abdominal migraine in pediatric populations.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
For patients with rheumatoid arthritis, studies show the benefits of certain dietary patterns and nutrients, including their possible protective effects on disease risk and progression.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
Insufficient pain management during childhood immunizations may lead to increased fear of needles and later health care avoidance.
An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
